摘要
合成了两个新的去甲基斑蝥素衍生物N-甘氨基-5,6-二溴-7-氧双环[2.2.1]庚烷-2,3-二甲酰亚胺(a)和N-3,5-二溴酪氨基-5,6-二溴-7-氧双环[2.2.1]庚烷-2,3-二甲酰亚胺(b),并对其进行了125I标记。最佳标记条件为:反应温度80℃,pH=6,标记反应时间30min。最高标记率分别达95.4%和91.6%。这两个新衍生物对癌细胞均有一定抑制作用,但衍生物a对癌细胞的抑制率较高,分别为20.0%(KB),0(HCT),50.5%(Bel)。两种125I标记衍生物在小白鼠体内的分布实验表明,它们在其心、肝、肺、肾和脾中均有较高的浓集。两个新衍生物能否被癌细胞摄取有待进一步研究。
Two kinds of norcantharidin derivatives(a,b) are synthetized, then they are labelled by 125 I. The best labelling conditions are: labelling temperature 80 ℃,labelling time 30 min,pH=6. The labelling yields are 95.4% and 91.6%,respectively. The two derivatives have inhibition to the carcinoma cells. The derivative(a) has well antitumor activity, and the inhibition yields to KB, HCT and Bel are 20.0%, 0 and 50.5%,respectively.The animal distribution experiments show the derivatives have the high uptake in heart, liver,lung,kideney and spleen. It should be studied whether they can be uptaken by tumor.
出处
《同位素》
CAS
1998年第2期95-99,共5页
Journal of Isotopes
关键词
去甲基斑蝥素
衍生物
动物体内分布
碘125标记
norcantharidin derivatives 125 I labelling animal distribution antitumor activity